ArticleScientific reports2026
Quantitative determination of al (III) traces in soft drink, pharmaceutical products and biological fluids of kidney failure and alzheimer disease patients using carbon sensor.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbon paste sensor based on p-chlorophenyl maleanilic acid (pCl-MA) as an ionophore was synthesized and investigated as an Al(III) ion selective sensor. The developed sensor shows Nernstian slope of 20.32 ± 1.18 mV decade− 1 over the working concentration range of 1.0 × 10− 6 − 1.0 × 10− 1 mol L− 1 of Al (III) ion with a detection limit of 3.3 × 10− 7 mol L− 1. The sensor exhibited a stable potential response in the pH range from 4.0 to 6.0 and a fast response time of 8 s. The prepared sensor indicated a very good selectivity to Al (III) over a variety of cations. The sensor could be easily employed for determination of Al (III) ions in pharmaceutical products, soft drink and biological fluids of kidney failure and Alzheimer disease patients. The reaction mechanism between pCL-MA and Al (III) was confirmed by FT-IR spectroscopic analysis, SEM and EDX.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.